Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Reexamination Certificate
2007-11-27
2007-11-27
Ketter, James (Department: 1636)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
C435S173500
Reexamination Certificate
active
10814966
ABSTRACT:
Optoinjection method for transiently permeabilizing a target cell by (a) illuminating a population of cells contained in a frame; (b) detecting at least one property of light directed from the frame; (c) locating a target cell by the property of light; and (d) irradiating the target cell with a pulse of radiation.
REFERENCES:
patent: 3674926 (1972-07-01), Dewey et al.
patent: 4000417 (1976-12-01), Adkisson et al.
patent: 4165149 (1979-08-01), Suzki et al.
patent: 4284897 (1981-08-01), Sawamura et al.
patent: 4395397 (1983-07-01), Shapiro
patent: 4532402 (1985-07-01), Overbeck
patent: 4624915 (1986-11-01), Schindler et al.
patent: 4629687 (1986-12-01), Schindler et al.
patent: 4803992 (1989-02-01), Lemelson
patent: 4998284 (1991-03-01), Bacus et al.
patent: 5013660 (1991-05-01), Kasuya et al.
patent: 5031099 (1991-07-01), Kettler
patent: 5035693 (1991-07-01), Kratzer et al.
patent: 5053693 (1991-10-01), Bohnert et al.
patent: 5089384 (1992-02-01), Hale
patent: 5093866 (1992-03-01), Douglas-Hamilton et al.
patent: 5103660 (1992-04-01), Johnson
patent: 5158889 (1992-10-01), Hirako et al.
patent: 5188633 (1993-02-01), Kratzer et al.
patent: 5202230 (1993-04-01), Kamentsky
patent: 5257182 (1993-10-01), Luck et al.
patent: 5272081 (1993-12-01), Weinreb et al.
patent: 5296963 (1994-03-01), Murakami et al.
patent: 5298963 (1994-03-01), Moriya et al.
patent: 5381224 (1995-01-01), Dixon et al.
patent: 5422720 (1995-06-01), Berndt
patent: 5523543 (1996-06-01), Hunter, Jr. et al.
patent: 5646411 (1997-07-01), Kain et al.
patent: 5672880 (1997-09-01), Kain
patent: 5690846 (1997-11-01), Okada et al.
patent: 5719391 (1998-02-01), Kain
patent: 5785703 (1998-07-01), Goodman et al.
patent: 5795755 (1998-08-01), Lemelson
patent: 5874266 (1999-02-01), Palsson
patent: 5890846 (1999-04-01), Clark et al.
patent: 5932872 (1999-08-01), Price
patent: 5952651 (1999-09-01), Morito et al.
patent: 6005256 (1999-12-01), McGlynn et al.
patent: 6007814 (1999-12-01), Scheinberg
patent: 6040139 (2000-03-01), Bova
patent: 6122396 (2000-09-01), King et al.
patent: 6143535 (2000-11-01), Palsson
patent: 6148096 (2000-11-01), Pressman et al.
patent: 6215892 (2001-04-01), Douglass et al.
patent: 6275777 (2001-08-01), Shimizu
patent: 6315772 (2001-11-01), Marchitto et al.
patent: 6381224 (2002-04-01), Lane et al.
patent: 6424863 (2002-07-01), Flock et al.
patent: 6642018 (2003-11-01), Koller et al.
patent: 6753161 (2004-06-01), Koller et al.
patent: 2002/0076744 (2002-06-01), Koller et al.
patent: 2003/0219892 (2003-11-01), Palsson et al.
patent: 0 662 512 (1995-07-01), None
patent: 63-259465 (1987-04-01), None
patent: 2054486 (1996-02-01), None
patent: WO89/01630 (1989-02-01), None
patent: WO97/11156 (1997-03-01), None
patent: WO98/42356 (1998-10-01), None
patent: WO98/52016 (1998-11-01), None
Andersen et al., “Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection in minimal residual disease,” Blood, 90: 4212-4221 (1997).
Brittberg et al., “Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation,” N.E.J.Med., 331:889-895 (1994).
Brockstein et al., “Tumor cell contamination of bone marrow harvest products: Clinical consequences in a cohort of advanced-stage breast cancer patients undergoing high-dose chemotherapy”, J. Hematotherapy, 5: 617-624 (1996).
Brugger et al., “Mobilization of Tumor Cells and Hematopoietic Progenitor Cells Into Peripheral Blood of Patients with Solid Tumors,” Blood, 83: 636-640 (1994).
Campana et al., “Detection of Minimal Residual Disease in Acute Leukemia: Methodological Advances and Clinical Significance,” Blood, 85: 1416-1434 (1995).
Chute et al., “Analysis of the steady-state dynamics organelle motion in cultured neurities,”Clin Exp Pharmco Physiol, 22: 360 (1995).
Clarke et al., “A recombinantbcl-xhd sadenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells,”Proc. Natl. Acad. Sci. USA, 92: 11024-11028 (1995).
Cossman et al., “Reed-Sternberg cell genome expression supports a B-cell lineage,”Blood, 94: 411-416 (1999).
Deisseroth et al., “Genetic marketing shows that Ph+cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML,”Blood,83: 3068-3076 (1994).
Dooley et al., “A Novel, Inexpensive Technique for the Removal of Breast Cancer Cells from Mobilized Peripheral Blood Stem Cell Products,”Blood, 88:252a, Abstracts 995, 438-11 (1996).
Elbashir, et al. “Duplexes of 21-nucleotide RNAs mediated RNA interference in cultured mammalian cells.” Nature, 411: 494-498 (2001).
Fields et al., “Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation,”J. Clin. Oncol., 14: 1868-1876 (1996).
Gazitt et al., “Purified CD34+Lin Thy+Stem Cells Do Not Contain Clonal Myeloma Cells,”Blood, 86: 381-389 (1995).
Gee, Adrian P., “Part 5: Autologous Bone Marrow Purging,”Bone Marrow Processing and Purging,248-328 (1991).
Grate et al., Laser-mediated, site specific inactivation of RNA transcripts,PNAS, 96:6131-6136 (1999).
Greer et al., “A Clonogenic Culture Method for the Identification of Breast Cancer Cells in Marrow Aspirates of Patients Receiving High-Dose Chemotherapy,”Blood, 88: 252a, Abstract 996, 439-II (1996).
Gribben et al., “Antibody-mediated Purging; Bone Marrow Transplantation,”Boston-Blackwell Scientific Publications, 149-163 (1994).
Merriam-Webster, Online Dictionary definition of “image”. From www.m-w.com, accessed Sep. 14, 2005. 2 pages.
Miller et al., “Rapid Killing of Single Neurons by Irradiation of Intracellular Injected Dye,”Science, 206: 702-704 (1979).
Niemz, M. H., “Laser-tissue interactions: Fundamentals and applications,” Springer-Verlag, (1996).
Nilius, et al. “A novel type of cardiac calcium channel in ventricular cells.” Nature, 316: 443-6 (1985).
Oh et al., “Phototoxicity of the Fluorescent Membrance Dyes PKH2 and PKH26 on the Human Hematopoietic KG1a Progenitor Cell Line,”Cytometry, 36: 312-318 (1999).
Oleinick et al., “The Photobiology of photodynamic therapy: Cellular targets and mechanisms,”Rad. Res., 150: S146-S156 (1998).
Palumbo, et al., “Targeted gene transfer in eukaryotic cells by dye-assisted laser optoporation,”J. Photochem. Photobiol., 36: 41-46 (1996).
Paulus et al., “Purging peripheral blood progenitor cell grafts from lymphoma cells: Quantitative comparison of immunomagnetic CD34+selection systems,”Stem Cells, 15: 297-304 (1997).
Pedersen, R. A., “Embryonic stem cells for medicine,”Sci. Amer.,280: 68-73 (1999).
Photonic Instruments, Inc.; Micro Point-Laser System for Bio-Medical and Life Sciences; Product Information Sheet, Apr. 1996.
Rill et al., “Direct Demonstration that Autologous Bone Marrow Transplantation for Solid Tumors Can Return a Multiplicity of Tumorigenic Cells,”Blood,; 84: 380-383 (1994).
Rowley, Scott D., “Pharmacological Purging of Malignant Cells; Bone Marrow Transplantation,”Boston-Blackwell Scientific Publications, 164:178 (1994).
Sagi, et al., “Gene delivery into prostate cancer cells by holmium laser application.” Prostate Cancer and Prostatic Diseases, 6: 127-130 (2003).
Schulze et al., “Tumor cell contamination of peripheral blood stem transplants and bone marrow in high-risk breast cancer patients,”Bone Marrow Transplant., 19: 1223-1228 (1997).
Schutze et al., “Identification of expressed genes by laser-mediated manipulation of single cells,”Nature Biotechnol., 16: 737-742 (1998).
Shirahata, et al., “New technique for gene transfection using laser irradiation.” J. Invest. Med., 49:
Eisfeld Timothy M.
Hanania Elie G.
Koller Manfred R.
Palsson Bernhard Ø.
Cyntellect, Inc.
Ketter James
Knobbe Martens Olson & Bear LLP
LandOfFree
Optoinjection methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Optoinjection methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optoinjection methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3852365